Literature DB >> 29671381

Minimal clinically important differences in treadmill, 6-minute walk, and patient-based outcomes following supervised and home-based exercise in peripheral artery disease.

Andrew W Gardner1, Polly S Montgomery1, Ming Wang2.   

Abstract

We estimated minimal clinically important differences (MCIDs) for small, moderate, and large changes in measures obtained from a standardized treadmill test, a 6-minute walk test, and patient-based outcomes following supervised and home-based exercise programs in symptomatic patients with peripheral artery disease (PAD). Patients were randomized to either 12 weeks of a supervised exercise program ( n=60), a home-based exercise program ( n=60), or an attention-control group ( n=60). Using the distribution-based method to determine MCIDs, the MCIDs for small, moderate, and large changes in peak walking time (PWT) in the supervised exercise group were 38, 95, and 152 seconds, respectively, and the changes in claudication onset time (COT) were 35, 87, and 138 seconds. Similar MCID scores were noted for the home-based exercise group. An anchor-based method to determine MCIDs yielded similar patterns of small, moderate, and large change scores in PWT and COT, but values were 1-2 minutes longer than the distribution approach. In conclusion, 3 months of supervised and home-based exercise programs for symptomatic patients with PAD results in distribution-based MCID small, moderate, and large changes ranging from 0.5 and 2.5 minutes for PWT and COT. An anchor-based approach yields higher MCID values, ranging from a minimum of 73 seconds for COT to a maximum of 4 minutes for PWT. The clinical implication is that a goal for eliciting MCIDs in symptomatic PAD patients through a walking exercise intervention is to increase PWT and COT by up to 4 minutes, which corresponds to two work stages during the standardized progressive treadmill test.

Entities:  

Keywords:  6-minute walk; claudication; minimal clinically important difference; peripheral artery disease (PAD); treadmill test

Mesh:

Year:  2018        PMID: 29671381      PMCID: PMC6062461          DOI: 10.1177/1358863X18762599

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  40 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  National health care costs of peripheral arterial disease in the Medicare population.

Authors:  Alan T Hirsch; Lacey Hartman; Robert J Town; Beth A Virnig
Journal:  Vasc Med       Date:  2008-08       Impact factor: 3.239

3.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

4.  Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease.

Authors:  Mary M McDermott; Jack M Guralnik; Michael H Criqui; Kiang Liu; Melina R Kibbe; Luigi Ferrucci
Journal:  Circulation       Date:  2014-07-01       Impact factor: 29.690

Review 5.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

Review 6.  The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease.

Authors:  William R Hiatt; R Kevin Rogers; Eric P Brass
Journal:  Circulation       Date:  2014-07-01       Impact factor: 29.690

7.  Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial.

Authors:  A W Gardner; L I Katzel; J D Sorkin; D D Bradham; M C Hochberg; W R Flinn; A P Goldberg
Journal:  J Am Geriatr Soc       Date:  2001-06       Impact factor: 5.562

8.  Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment.

Authors:  M M McDermott; P Greenland; K Liu; J M Guralnik; M H Criqui; N C Dolan; C Chan; L Celic; W H Pearce; J R Schneider; L Sharma; E Clark; D Gibson; G J Martin
Journal:  JAMA       Date:  2001-10-03       Impact factor: 56.272

9.  Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States.

Authors:  Elizabeth M Mahoney; Kaijun Wang; Hong H Keo; Sue Duval; Kim G Smolderen; David J Cohen; Gabriel Steg; Deepak L Bhatt; Alan T Hirsch
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-10-12

10.  Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.

Authors:  Mary McGrae McDermott; Kiang Liu; Philip Greenland; Jack M Guralnik; Michael H Criqui; Cheeling Chan; William H Pearce; Joseph R Schneider; Luigi Ferrucci; Lillian Celic; Lloyd M Taylor; Ed Vonesh; Gary J Martin; Elizabeth Clark
Journal:  JAMA       Date:  2004-07-28       Impact factor: 56.272

View more
  27 in total

1.  Comparing 6-minute walk versus treadmill walking distance as outcomes in randomized trials of peripheral artery disease.

Authors:  Mary M McDermott; Jack M Guralnik; Lu Tian; Lihui Zhao; Tamar S Polonsky; Melina R Kibbe; Michael H Criqui; Dongxue Zhang; Michael S Conte; Kathryn Domanchuk; Lingyu Li; Robert Sufit; Christiaan Leeuwenburgh; Luigi Ferrucci
Journal:  J Vasc Surg       Date:  2019-12-23       Impact factor: 4.268

2.  Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease: The COCOA-PAD Pilot Randomized Clinical Trial.

Authors:  Mary M McDermott; Michael H Criqui; Kathryn Domanchuk; Luigi Ferrucci; Jack M Guralnik; Melina R Kibbe; Kate Kosmac; Christopher M Kramer; Christiaan Leeuwenburgh; Lingyu Li; Donald Lloyd-Jones; Charlotte A Peterson; Tamar S Polonsky; James H Stein; Robert Sufit; Linda Van Horn; Francisco Villarreal; Dongxue Zhang; Lihui Zhao; Lu Tian
Journal:  Circ Res       Date:  2020-02-14       Impact factor: 17.367

3.  Diet is associated with ankle-brachial index, inflammation, and ambulation in patients with intermittent claudication.

Authors:  Andrew W Gardner; Polly S Montgomery; Ming Wang; Biyi Shen; Ana I Casanegra; Federico Silva-Palacios; Allen W Knehans
Journal:  J Vasc Surg       Date:  2020-02-28       Impact factor: 4.268

4.  Leg heat therapy improves perceived physical function but does not enhance walking capacity or vascular function in patients with peripheral artery disease.

Authors:  Jacob C Monroe; Chen Lin; Susan M Perkins; Yan Han; Brett J Wong; Raghu L Motaganahalli; Bruno T Roseguini
Journal:  J Appl Physiol (1985)       Date:  2020-10-01

5.  Association between calf muscle oxygen saturation with ambulatory function and quality of life in symptomatic patients with peripheral artery disease.

Authors:  Andrew W Gardner; Polly S Montgomery; Ming Wang; Biyi Shen
Journal:  J Vasc Surg       Date:  2020-02-17       Impact factor: 4.268

6.  Claudicating patients with peripheral artery disease have meaningful improvement in walking speed after supervised exercise therapy.

Authors:  Hafizur Rahman; Iraklis I Pipinos; Jason M Johanning; George Casale; Mark A Williams; Jonathan R Thompson; Yohanis O'Neill-Castro; Sara A Myers
Journal:  J Vasc Surg       Date:  2021-05-31       Impact factor: 4.268

7.  Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical Trial.

Authors:  Mary M McDermott; Bonnie Spring; Lu Tian; Diane Treat-Jacobson; Luigi Ferrucci; Donald Lloyd-Jones; Lihui Zhao; Tamar Polonsky; Melina R Kibbe; Lydia Bazzano; Jack M Guralnik; Daniel E Forman; Al Rego; Dongxue Zhang; Kathryn Domanchuk; Christiaan Leeuwenburgh; Robert Sufit; Brittany Smith; Todd Manini; Michael H Criqui; W Jack Rejeski
Journal:  JAMA       Date:  2021-04-06       Impact factor: 56.272

Review 8.  Assessing health-related quality of life among patients with peripheral artery disease: A review of the literature and focus on patient-reported outcome measures.

Authors:  Aishwarya Raja; John Spertus; Robert W Yeh; Eric A Secemsky
Journal:  Vasc Med       Date:  2020-12-09       Impact factor: 3.239

Review 9.  Supervised Resistance Training on Functional Capacity, Muscle Strength and Vascular Function in Peripheral Artery Disease: An Updated Systematic Review and Meta-Analysis.

Authors:  Elizabeth E Blears; Jessica K Elias; Christian Tapking; Craig Porter; Victoria G Rontoyanni
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

10.  A systematic review of the role of heat therapy for patients with intermittent claudication due to peripheral artery disease.

Authors:  Amy E Harwood; Christopher Ja Pugh; Charles J Steward; Campbell Menzies; C Doug Thake; Tom Cullen
Journal:  Vasc Med       Date:  2021-02-15       Impact factor: 3.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.